Lynelle Hoch - President, Cell Therapy Org. at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Cell Therapy Org.
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lynelle Hoch since 4/23/2024

Holdings reported by Lynelle Hoch for Bristol Myers Squibb Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 4.71K $297K $63.11 Mar 10, 2025 Direct
Market Share Units 5.02K $266K $52.99 Mar 10, 2025 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 1.73K $92.8K $53.79 Mar 10, 2024 Direct
Performance Shares 7.53K Mar 10, 2025 Direct Common Stock, $0.10 par value

Transactions reported by Lynelle Hoch for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.